Tech Company Financing Transactions

Ignyta Funding Round

City Hill Ventures, Colt Ventures and private investors participated in a $6 million Series B capital raise for Ignyta. This VC investment round was announced on 1/1/2013.

Transaction Overview

Company Name
Announced On
1/1/2013
Transaction Type
Venture Equity
Amount
$6,000,000
Round
Series B
Investors
Proceeds Purpose
The company plans to use proceeds of its current round in 2013 to begin clinical studies to confirm its molecular based assay for diagnosing RA at its earliest, most-treatable stages.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
11095 Flintkote Avenue d
San Diego, CA 92121
USA
Email Address
Overview
Ignyta is developing leading cancer treatments by developing selective tyrosine kinase inhibitors of the TrkA, TrkB, TrkC, ROS1 and ALK proteins.
Profile
Ignyta LinkedIn Company Profile
Social Media
Ignyta Company Twitter Account
Company News
Ignyta News
Facebook
Ignyta on Facebook
YouTube
Ignyta on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Jonathan Lim
  Jonathan Lim LinkedIn Profile  Jonathan Lim Twitter Account  Jonathan Lim News  Jonathan Lim on Facebook
Chief Financial Officer
Jacob Chacko
  Jacob Chacko LinkedIn Profile  Jacob Chacko Twitter Account  Jacob Chacko News  Jacob Chacko on Facebook
Chief Medical Officer
Adrian Senderowicz
  Adrian Senderowicz LinkedIn Profile  Adrian Senderowicz Twitter Account  Adrian Senderowicz News  Adrian Senderowicz on Facebook
Chief Operating Officer
Zachary Hornby
  Zachary Hornby LinkedIn Profile  Zachary Hornby Twitter Account  Zachary Hornby News  Zachary Hornby on Facebook
Chief Scientific Officer
Robert Wild
  Robert Wild LinkedIn Profile  Robert Wild Twitter Account  Robert Wild News  Robert Wild on Facebook
VP - General Counsel
Matt Onaitis
  Matt Onaitis LinkedIn Profile  Matt Onaitis Twitter Account  Matt Onaitis News  Matt Onaitis on Facebook


 

 

Browse more venture capital transactions:

Prev: 1/1/2013: The Fancy venture capital transaction
Next: 1/2/2013: NanoHorizons venture capital transaction

 

Share this article

 


Where The Data Comes From

Our team works diligently to report on every notable VC transaction. VC transactions on this site come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary